Objective: To explore an intervention method to reduce the mortality of alloxan diabetes model, and to preliminarily analyze the mechanism of alloxan induced animal death. Methods: Healthy New Zealand rabbits were randomly divided into injection group, control group, experimental group and blank group. The single injection group was injected with 100 mg/kg alloxan once. The control group was given 5% glucose solution and 100 mg/kg alloxan was injected in two times. The experimental group was given 5% glucose solution orally, 100 mg/kg alloxan, 7 mL 0.9% NaCl intravenously and 5 mL 5% glucose intraperitoneally immediately, and blood glucose was continuously monitored, 10 mL 5% glucose intravenously and 10 mL 5% glucose intraperitoneally every 4 h in the hypoglycemic stage. The blank group does nothing. Liver and kidney tissues at different time periods were stained with HE and organ index was evaluated.Results: 1) A single injection of 100 mg/kg alloxan without any intervention resulted in 100% mortality. Before modeling, oral administration of 5% glucose solution, divided into two injections of 100 mg/kg alloxan, mortality reached 100%; A single injection of 100 mg/kg alloxan and continuous intervention of normal saline and glucose for 20 h can significantly reduce the mortality of alloxan induced diabetic rabbit model. 2) Liver and kidney tissues were damaged in different degrees at different time periods, and liver and kidney indexes were significantly increased after alloxan injection compared with the normal group, with statistical significance (P > 0.05). Conclusion: 1) Every 4 hours of hypoglycemia, 10 ml 5% glucose was injected intravenously 10 ml 5% glucose intraperitoneally. It can reduce the death rate of alloxan diabetic rabbit model and shorten the time of blood glucose measurement. 2) After the injection of alloxan, acute lesions of liver and kidney may occur in different degrees, or one of the causes of acute death of experimental animals.
References
[1]
Armstrong, D.G., Swerdlow, M.A., Armstrong, A.A., et al. (2020) Five Year Mortality and Direct Costs of Care for People with Diabetic Foot Complications Are Comparable to Cancer. Journal of Foot and Ankle Research, 13, 16. https://doi.org/10.1186/s13047-020-00383-2
[2]
Wei, J. and Zhou, H. (2019) Research Progress on the Mechanism of Wound Healing of Diabetic Foot Ulcer. Youjiang Medical Journal, 49, 621-624.
[3]
Min, A.Y., Yoo, J.-M., Sok, D.-E., et al. (2020) Mulberry Fruit Prevents Diabetes and Diabetic Dementia by Regulation of Blood Glucose through Upregulation of Antioxidative Activities and CREB/BDNF Pathway in Alloxan-Induced Diabetic Mice. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 1298691. https://doi.org/10.1155/2020/1298691
[4]
Badin, J.K., Progar, V., Pareddy, A., et al. (2019) Effect of Age on Diabetogenicity of Alloxan in Ossabaw Miniature Swine. Comparative Medicine, 69, 114-122. https://doi.org/10.30802/AALAS-CM-18-000037
[5]
Matsuura, Y., Yamashita, A., Zhao, Y., et al. (2017) Altered Glucose Metabolism and Hypoxic Response in Alloxan-Induced Diabetic Atherosclerosis in Rabbits. PLOS ONE, 12, e0175976. https://doi.org/10.1371/journal.pone.0175976
[6]
Elseweidy, M.M., Aly, S.I., Hammad, S.K., et al. (2020) Early Myocardial Injury Biomarkers in Diabetic Hyperlipidemic Rats: Impact of 10-Dehydrogingerdione and Vitamin D3. Experimental Biology and Medicine, 245, 1326-1334. https://doi.org/10.1177/1535370220943124
[7]
Fan, X., Xiaoqin, L., Potts, B., et al. (2011) Topical Application of L-Arginine Blocks Advanced Glycation by Ascorbic Acid in the Lens of HSVCT2 Transgenic Mice. Molecular Vision, 17, 2221-2227.
[8]
Mumtaz, F.H., Lau, D.H.W., Siddiqui, E.J., et al. (2006) Changes in Cholinergic and Purinergic Neurotransmission in the Diabetic Rabbit Bladder. In Vivo, 20, 1-4.
[9]
Wang, J., Wan, R., Mo, Y., et al. (2010) Creating a Long-Term Diabetic Rabbit Model. Journal of Diabetes Research, 2010, Article ID: 289614. https://doi.org/10.1155/2010/289614
[10]
Bacevic, M., Rompen, E., Radermecker, R., et al. (2020) Practical Considerations for Reducing Mortality Rates in Alloxan-Induced Diabetic Rabbits. Heliyon, 6, E04103. https://doi.org/10.1016/j.heliyon.2020.e04103
[11]
Lenzen, S. (2008) The Mechanisms of Alloxan-and Streptozotocin-Induced Diabetes. Diabetologia, 51, 216-226. https://doi.org/10.1007/s00125-007-0886-7
[12]
Federiuk, I.F., Casey, H.M., Quinn, M.J., Wood, M.D. and Ward, K.W. (2004) Induction of Type-1 Diabetes Mellitus in Laboratory Rats by Use of Alloxan: Route of Administration, Pitfalls, and Insulin Treatment. Comparative Medicine, 54, 252-257.
[13]
Queiroz, L., et al. (2021) Endangered Lymphocytes: The Effects of Alloxan and Streptozotocin on Immune Cells in Type 1 Induced Diabetes. Mediators of Inflammation, 2021, Article ID: 9940009. https://doi.org/10.1155/2021/9940009
[14]
Radenković, M., Stojanović, M. and Prostran, M. (2016) Experimental Diabetes Induced by Alloxan and Streptozotocin: The Current State of the Art. Journal of Pharmacological and Toxicological Methods, 78, 13-31. https://doi.org/10.1016/j.vascn.2015.11.004
[15]
Mir, M.S., Darzi, M.M., Khan, H.M., et al. (2013) Pathomorphological Effects of Alloxan Induced Acute Hypoglycaemia in Rabbits. Alexandria Journal of Medicine, 49, 343-353. https://doi.org/10.1016/j.ajme.2013.03.007
[16]
Tasaka, Y., Inoue, Y., Matsumoto, H. and Hirata, Y. (1988) Changes in Plasma Glucagon, Pancreatic Polypeptide and Insulin during Development of Alloxan Diabetes Mellitus in Dog. Endocrinologia Japonica, 35, 399-404. https://doi.org/10.1507/endocrj1954.35.399
[17]
Sun, W.T., Lei, C.L., Bi, C.C., et al. (2010) Effect of Alloxan Time Administer Drug on Establishing Diabetic Rabbit Model. International Journal of Ophthalmology, 3, 200-202.
[18]
Misra, M. and Aiman, U. (2012) Alloxan: An Unpredictable Drug for Diabetes Induction? Indian Journal of Pharmacology, 44, 538-539.
[19]
Golay, A., Zech, L., Shi, M.Z., et al. (1986) Role of Insulin in Regulation of High Density Lipoprotein Metabolism. Journal of Lipid Research, 28, 10-18. https://doi.org/10.1016/S0022-2275(20)38727-7
[20]
Ighodaro, O.M., Adeosun, A.M. and Akinloye, O.A. (2017) Alloxan-Induced Diabetes, a Common Model for Evaluating the Glycemic-Control Potential of Therapeutic Compounds and Plants Extracts in Experimental Studies. Medicina, 53, 365-374. https://doi.org/10.1016/j.medici.2018.02.001
[21]
Elsner, M., Tiedge, M., Guldbakke, B., Munday, R. and Lenzen, S. (2002) Importance of the GLUT2 Glucose Transporter for Pancreatic Beta Cell Toxicity of Alloxan. Diabetologia, 45, 1542-1549. https://doi.org/10.1007/s00125-002-0955-x
[22]
Bingham, J.T., Etz, B.D., DuClos, J.M., et al. (2021) Structure and Reactivity of Alloxan Monohydrate in the Liquid Phase. The Journal of Organic Chemistry, 86, 14553-14562. https://doi.org/10.1021/acs.joc.1c01389
[23]
Bahar, E., Akter, K.M., Lee, G.H., et al. (2017) β-Cell Protection and Antidiabetic Activities of Crassocephalum crepidioides (Asteraceae) Benth. S. Moore Extract against Alloxan-Induced Oxidative Stress via Regulation of Apoptosis and Reactive Oxygen Species (ROS). BMC Complementary and Alternative Medicine, 17, Article No. 179. https://doi.org/10.1186/s12906-017-1697-0
[24]
Aloke, C., Nwachukwu, N., Obasi, N.A., et al. (2021) Antihyperglycemic, Antihyperlipidemic and Hepatoprotective Effects of Ficus ottoniifolia (Miq.) Miq. Supplementation in Alloxan-Induced Diabetic Rats. Avicenna Journal of Phytomedicine, 11, 428-435.
[25]
Dra, L.A., Sellami, S., Rais, H., et al. (2019) Antidiabetic Potential of Caralluma europaea against Alloxan-Induced Diabetes in Mice. Saudi Journal of Biological Sciences, 26, 1171-1178. https://doi.org/10.1016/j.sjbs.2018.05.028
[26]
McDaniel, M.L., Bry, C.G., Fink, C.J., et al. (1979) Studies on the Site of Interaction for Ninhydrin, Alloxan, and D-Glucose in Insulin Secretion by Isolated Islets in Vitro. Endocrinology, 105, 1446-1451. https://doi.org/10.1210/endo-105-6-1446
